Insured Price of Glivec Set at 25,000 Won on Condition of 30% of Complementary Donation

The insured price of Glivec, which has attracted attention as a treatment for marrow-type chronic leukemia, has increased to 25,000 won on the condition that 30% of the quantity of the drug would be donated to patients suffering from the disease. However, since the price was revised under the principle of maintaining 17,862 won which was originally set, it remains to be seen whether Novartis, t...